{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:12:18Z","timestamp":1793146338132,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bladder cancer is one of the top ten most common cancers and top ten causes of cancer death globally. 5-year survival rates have decreased in Australia from 66% to 55% in the past three decades. The current gold standard for diagnosis is cystoscopy. However, cystoscopies are an invasive and health-resource intensive procedure which has sub-optimal sensitivity for flat lesions such as CIS (carcinoma in situ) and low specificity for differentiating inflammation from cancer - hence requiring biopsies under anesthesia. Frequent and life-long surveillance cystoscopy is required for most patients since there are high rates of progression and local recurrence in high-risk non-muscle invasive cancer (NMIBC) as well as poor outcomes associated with delayed detection of muscle-invasive bladder cancer (MIBC). There is an unmet need for a non-invasive test to provide better discrimination and risk-stratification of bladder cancer which could aid clinicians by improving patient selection for cystoscopy; enhanced risk stratification methods may guide the frequency of surveillance cystoscopies and inform treatment choices. Exosomes, which are nano-sized extracellular vesicles containing genetic material and proteins, have been shown to have functional roles in the development and progression of bladder cancer. Exosomes have also been demonstrated to be a robust source of potential biomarkers for bladder cancer diagnosis and prognosis and may also have roles as therapeutic agents. In this review, we summarize the latest evidence of biological roles of exosomes in bladder cancer and highlight their clinical significance in bladder cancer diagnosis, surveillance and treatment.<\/jats:p>","DOI":"10.3389\/fonc.2022.1019391","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T07:31:00Z","timestamp":1663659060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance"],"prefix":"10.3389","volume":"12","author":[{"given":"Nicholas","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashan","family":"Canagasingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Shanmugasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J Clin"},{"key":"B2","volume-title":"Stat database: Incidence - SEER research data 8 registries","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of urology (Eau) prognostic factor risk groups for non\u2013Muscle-Invasive bladder cancer (Nmibc) incorporating the who 2004\/2016 and who 1973 classification systems for grade: An update from the eau nmibc guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.077","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in a united states population","volume":"198","author":"Ravvaz","year":"2017","journal-title":"J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000016426","article-title":"Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients","volume":"98","author":"Lu","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA: A Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA: A Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of urology guidelines on non-Muscle-Invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/1756287217720401","article-title":"Optical improvements in the diagnosis of bladder cancer: Implications for clinical practice","volume":"9","author":"Schubert","year":"2017","journal-title":"Ther Adv Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21947","article-title":"High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin","volume":"126","author":"Renshaw","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bju.14459","article-title":"Does urinary cytology have a role in haematuria investigations","volume":"123","author":"Tan","year":"2019","journal-title":"BJU Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21764","article-title":"The positive predictive value of \u201cSuspicious for high-grade urothelial carcinoma\u201d in urinary tract cytology specimens: A single-institution study of 665 cases","volume":"124","author":"Joudi","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.08.057","article-title":"Comprehensive mutation analysis of the tert promoter in bladder cancer and detection of mutations in voided urine","volume":"65","author":"Hurst","year":"2014","journal-title":"Eur Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)64665-2","article-title":"Frequent Fgfr3 mutations in papillary non-invasive bladder (Pta) tumors","volume":"158","author":"Billerey","year":"2001","journal-title":"Am J Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2800","article-title":"Frequent truncating mutations of Stag2 in bladder cancer","volume":"45","author":"Solomon","year":"2013","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/path.4017","article-title":"Cdkn2a homozygous deletion is associated with muscle invasion in Fgfr3-mutated urothelial bladder carcinoma","volume":"227","author":"Rebouissou","year":"2012","journal-title":"J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-09-0898","article-title":"Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer","volume":"15","author":"Platt","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.69","article-title":"Her2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: Analysis by dual-color in situ hybridization","volume":"24","author":"Ching","year":"2011","journal-title":"Modern Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: Biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Bioscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041713","article-title":"Role of exosomal mirna in bladder cancer: A promising liquid biopsy biomarker","volume":"22","author":"Piao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052744","article-title":"Extracellular vesicles as biomarkers carriers in bladder cancer: Diagnosis, surveillance, and treatment","volume":"22","author":"Georgantzoglou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","article-title":"Review of the isolation, characterisation, biological function, and multifarious therapeutic approaches of exosomes","volume":"8","author":"Gurunathan","year":"2019","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.680018","article-title":"Exosomal rna as biomarkers and the therapeutic potential of exosome vectors","volume":"12","author":"L\u00e4sser","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-017-0706-8","article-title":"Role of exosomal proteins in cancer diagnosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.53671","article-title":"Regulation of exosome production and cargo sorting","volume":"17","author":"Wei","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell\u2013cell communication by extracellular vesicles","volume":"5","author":"Van Niel","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2019.02.005","article-title":"Ticket to a bubble ride: Cargo sorting into exosomes and extracellular vesicles","volume":"1867","author":"Anand","year":"2019","journal-title":"Biochim Biophys Acta (BBA)  Proteins Proteomics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-020-03703-z","article-title":"Inside(Sight) of tiny communicator: Exosome biogenesis, secretion, and uptake","volume":"467","author":"Jadli","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.128868","article-title":"Analysis of escrt functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J Cell Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12803","article-title":"The role of lipids in exosome biology and intercellular communication: Function, analytics and applications","volume":"22","author":"Donoso-Quezada","year":"2021","journal-title":"Traffic"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.013","article-title":"Biodistribution and delivery efficiency of unmodified tumor-derived exosomes","volume":"199","author":"Smyth","year":"2015","journal-title":"J Control Release"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664904","article-title":"Insights into exosomal non-coding rnas sorting mechanism and clinical application","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/cells9041044","article-title":"Sorting mechanisms for micrornas into extracellular vesicles and their associated diseases","volume":"9","author":"Groot","year":"2020","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71982","article-title":"Selective sorting of micrornas into exosomes by phase-separated Ybx1 condensates","volume":"10","author":"Liu","year":"2021","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12032-021-01621-8","article-title":"Exosome application in tumorigenesis: Diagnosis and treatment of melanoma","volume":"39","author":"Karami Fath","year":"2022","journal-title":"Med Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2017.10.17","article-title":"Cancer exosomes in urine: A promising biomarker source","volume":"8","author":"Panfoli","year":"2017","journal-title":"Trans Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: Key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-017-0714-8","article-title":"Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding rna-Uca1","volume":"16","author":"Xue","year":"2017","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.02.035","article-title":"Bladder cancer exosomes contain edil-3\/Del1 and facilitate cancer progression","volume":"192","author":"Beckham","year":"2014","journal-title":"J Urol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061419","article-title":"Exosome-derived Linc00960 and Linc02470 promote the epithelial-mesenchymal transition and aggressiveness of bladder cancer cells","volume":"9","author":"Huang","year":"2020","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4933","article-title":"Bladder cancer Cell\u2212Secreted exosomal Mir\u221221 activates the Pi3k\/Akt pathway in macrophages to promote cancer progression","volume":"56","author":"Lin","year":"2020","journal-title":"Int J Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006682","article-title":"Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells","volume":"294","author":"Wu","year":"2019","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","article-title":"Downregulated exosomal microrna-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating pten","volume":"44","author":"Shan","year":"2021","journal-title":"Cell Oncol (Dordrecht)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14969","article-title":"Mir-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma","volume":"8","author":"Matsuzaki","year":"2017","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31849","article-title":"Urinary cell-free microrna biomarker could discriminate bladder cancer from benign hematuria","volume":"144","author":"Piao","year":"2019","journal-title":"Int J Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s186108","article-title":"Urinary exosomal expression of long non-coding rnas as diagnostic marker in bladder cancer","volume":"10","author":"Yazarlou","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6010179","article-title":"A pilot study on the potential of rna-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer","volume":"6","author":"Perez","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0147236","DOI":"10.1371\/journal.pone.0147236","article-title":"Expression of the long non-coding rna hotair correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes","volume":"11","author":"Berrondo","year":"2016","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding rnas in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/pr3008732","article-title":"Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients","volume":"11","author":"Chen","year":"2012","journal-title":"J Proteome Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.667212","article-title":"Combination of urine exosomal mrnas and lncrnas as novel diagnostic biomarkers for bladder cancer","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2016.10.008","article-title":"Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression","volume":"98","author":"Andreu","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9038808","article-title":"Urinary exosomal long noncoding rna terc as a noninvasive diagnostic and prognostic biomarker for bladder urothelial carcinoma","volume":"2022","author":"Chen","year":"2022","journal-title":"J Immunol Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1021\/pr700775x","article-title":"Isolation and identification of potential urinary microparticle biomarkers of bladder cancer","volume":"7","author":"Smalley","year":"2008","journal-title":"J Proteome Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.924.584","article-title":"Epidermal growth factor receptor and bladder cancer","volume":"78","author":"Colquhoun","year":"2002","journal-title":"Postgrad Med J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/s41598-020-62753-x","article-title":"Urinary exosomes from bladder cancer patients show a residual cancer phenotype despite complete pathological downstaging","volume":"10","author":"Hiltbrunner","year":"2020","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133242","article-title":"Proteomic profiling of tissue exosomes indicates continuous release of malignant exosomes in urinary bladder cancer patients, even with pathologically undetectable tumour","volume":"13","author":"Eldh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704703","article-title":"Biological roles and clinical significance of exosome-derived noncoding rnas in bladder cancer","volume":"11","author":"Tong","year":"2021","journal-title":"Front Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-2124","article-title":"Ckap4, a Dkk1 receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy","volume":"25","author":"Kimura","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/srep42339","article-title":"Microrna-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Mikamori","year":"2017","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal pd-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (Dc) derived-exosomes: Results of thefirst phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J Trans Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in nsclc","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1021\/acssensors.2c00259","article-title":"Fluorescence analysis of circulating exosomes for breast cancer diagnosis using a sensor array and deep learning","volume":"7","author":"Jin","year":"2022","journal-title":"ACS Sens"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b07584","article-title":"Integrated magneto-electrochemical sensor for exosome analysis","volume":"10","author":"Jeong","year":"2016","journal-title":"ACS Nano"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2886","article-title":"Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor","volume":"32","author":"Im","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00258","article-title":"Non-invasive detection of exosomal micrornas Via tethered cationic lipoplex nanoparticles (Tcln) biochip for lung cancer early detection","volume":"11","author":"Liu","year":"2020","journal-title":"Front Genet"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174435","article-title":"Recent advances in exosome-based drug delivery for cancer therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1019391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T07:31:06Z","timestamp":1663659066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1019391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":74,"alternative-id":["10.3389\/fonc.2022.1019391"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1019391","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"1019391"}}